United Therapeutics buy StockNews.com
Start price
31.12.24
/
50%
€342.80
Target price
31.12.25
-
Performance (%)
24.21%
End price
03.01.26
€425.80
Summary
This prediction ended on 03.01.26 with a price of €425.80. The prediction had a final performance of 24.21%. StockNews_com has a follow-up prediction for United Therapeutics where he still thinks United Therapeutics is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| United Therapeutics | 2.647% | 2.647% | 99.840% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by StockNews_com for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for UTHR provided by MarketBeat
In the thread Trading United Therapeutics
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten